Novartis AG Cash Flows From Used In Operating Activities Continuing Operations
Novartis AG (NVS) reported Cash Flows From Used In Operating Activities Continuing Operations of $19.14 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations · last filed 2026-02-04
- Novartis AG cash flows from used in operating activities continuing operations for the quarter ending 2024-06-30 was $4.88B, a 38.61% increase year-over-year.
- Novartis AG cash flows from used in operating activities continuing operations for the quarter ending 2023-06-30 was $3.52B.
- Novartis AG cash flows from used in operating activities continuing operations for the quarter ending 2020-06-30 was $3.96B, a 27.32% increase year-over-year.
- Novartis AG cash flows from used in operating activities continuing operations for the quarter ending 2019-06-30 was $3.11B, a 11.42% decline year-over-year.
| Period end | Cash Flows From Used In Operating Activities Continuing Operations 3 month | Cash Flows From Used In Operating Activities Continuing Operations 3 month as first filed | Cash Flows From Used In Operating Activities Continuing Operations 6 month | Cash Flows From Used In Operating Activities Continuing Operations 6 month as first filed | Cash Flows From Used In Operating Activities Continuing Operations 12 month | Cash Flows From Used In Operating Activities Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $19.14B 20-F · filed 2026-02-04 | |||||
| 2024-12-31 | $17.62B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $4.88B 6-K · filed 2024-07-18 | $7.14B 6-K · filed 2024-07-18 | ||||
| 2023-12-31 | $14.22B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $3.52B 6-K · filed 2024-07-18 | $6.37B 6-K · filed 2024-07-18 | ||||
| 2022-12-31 | $13.04B 20-F · filed 2025-01-31 | |||||
| 2021-12-31 | $13.37B 20-F · filed 2024-01-31 | $15.07B 20-F · filed 2022-02-02 | ||||
| 2020-12-31 | $13.65B 20-F · filed 2022-02-02 | |||||
| 2020-06-30 | $3.96B 6-K · filed 2020-07-21 | $6.49B 6-K · filed 2020-07-21 | ||||
| 2019-12-31 | $13.55B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $3.11B 6-K · filed 2020-07-21 | $5.45B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $13.05B 20-F · filed 2021-01-26 | |||||
| 2018-06-30 | $3.51B 6-K · filed 2019-07-18 | $3.94B 6-K · filed 2018-07-18 | $5.89B 6-K · filed 2019-07-18 | $6.46B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $11.42B 20-F · filed 2020-01-29 | $12.62B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $3.58B 6-K · filed 2018-07-18 | $5.63B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $11.47B 6-K · filed 2018-01-24 | |||||
| 2015-12-31 | $12.09B 6-K · filed 2018-01-24 |